APA (7th ed.) Citation

Değer, M. D., Yıldız, H. A., İncir, C., Özer, S., Sarıkaya, A. E., Ergör, G., . . . Esen, A. A. (2023). Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial. Journal of Urological Surgery, 10(1), 36. https://doi.org/10.4274/jus.galenos.2022.2022.0037

Chicago Style (17th ed.) Citation

Değer, Müslim Doğan, et al. "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial." Journal of Urological Surgery 10, no. 1 (2023): 36. https://doi.org/10.4274/jus.galenos.2022.2022.0037.

MLA (9th ed.) Citation

Değer, Müslim Doğan, et al. "Efficacy and Safety of a 5-Alpha Reductase Inhibitor, Dutasteride, Added to Bacillus Calmette-Guérin Immunotherapy for Prevention of Recurrence and Progression of Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer: A Single-Arm, Phase 2 Clinical Trial." Journal of Urological Surgery, vol. 10, no. 1, 2023, p. 36, https://doi.org/10.4274/jus.galenos.2022.2022.0037.